Scott Bizily is CLO at 4D Molecular Therapeutics, Inc. (FDMT). They have made 3 open-market trades across 2 companies since 2022, most recently 2026-09-16.
CIK 0001920738
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 3 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| FDMT | 8,617 | $105K |
| FMDT | 1,737 | — |
| Total | $105K |
Shares reported on the most recent Form 4, priced at the 2026-09-22 close. 1 holding could not be priced and is excluded from the total.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| FDMT | SELL · 10b5-1 | 2026-09-16 | 2026-09-22 | $13.65 | $22K | -12.7% | — | — |
| FDMT | SELL · 10b5-1 | 2026-09-01 | 2026-09-03 | $14.00 | $8K | -6.0% | -11.7% | — |
| FDMT | SELL · 10b5-1 | 2026-08-13 | 2026-08-17 | $12.10 | $40K | +4.1% | -4.0% | — |
| FDMT | SELL · 10b5-1 | 2026-06-30 | 2026-07-02 | $14.00 | $92K | -9.9% | -22.5% | +10.1% |
| FDMT | SELL | 2026-06-23 | 2026-06-25 | $12.00 | $118K | +11.3% | -11.3% | +28.1% |
| FDMT | SELL · 10b5-1 | 2025-12-16 | 2025-12-19 | $10.90 | $18K | -16.3% | -12.9% | +2.6% |
| FDMT | SELL · 10b5-1 | 2025-11-17 | 2025-11-19 | $10.59 | $17K | -7.9% | -21.1% | -13.8% |
| FDMT | SELL · 10b5-1 | 2025-10-24 | 2025-10-27 | $12.00 | $32K | -10.8% | -10.2% | -34.9% |
| FDMT | SELL · 10b5-1 | 2025-10-16 | 2025-10-20 | $10.17 | $17K | +1.6% | -3.1% | -31.6% |
| FDMT | SELL · 10b5-1 | 2025-10-09 | 2025-10-14 | $10.00 | $24K | +12.8% | +2.3% | -25.4% |
| FDMT | SELL · 10b5-1 | 2025-09-23 | 2025-09-26 | $8.00 | $19K | +16.0% | +47.3% | -4.3% |
| FDMT | SELL · 10b5-1 | 2024-09-16 | 2024-09-18 | $16.33 | $8K | -37.8% | -50.9% | -63.7% |
| FDMT | SELL · 10b5-1 | 2024-08-19 | 2024-08-21 | $15.00 | $8K | -2.8% | -21.6% | -42.8% |
| FDMT | SELL · 10b5-1 | 2024-07-16 | 2024-07-18 | $27.11 | $47K | +12.6% | -3.5% | -43.2% |
| FDMT | SELL · 10b5-1 | 2024-07-11 | 2024-07-15 | $25.00 | $50K | -32.4% | -47.3% | -67.0% |
| FDMT | SELL · 10b5-1 | 2024-07-01 | 2024-07-03 | $21.36 | $181K | +29.4% | -22.2% | -49.7% |
| FDMT | SELL · 10b5-1 | 2024-06-17 | 2024-06-20 | $23.71 | $41K | -10.1% | -25.4% | -26.5% |
| FDMT | SELL · 10b5-1 | 2024-05-16 | 2024-05-20 | $25.45 | $45K | -4.3% | -9.8% | -41.3% |
| FDMT | SELL · 10b5-1 | 2024-04-16 | 2024-04-18 | $25.74 | $45K | -2.8% | +5.6% | -26.0% |
| FDMT | SELL · 10b5-1 | 2024-04-01 | 2024-04-03 | $31.78 | $518K | -6.8% | -6.4% | -26.9% |
| FDMT | SELL · 10b5-1 | 2024-03-27 | 2024-03-29 | $35.04 | $409K | -15.3% | -23.7% | -34.1% |
| FDMT | SELL · 10b5-1 | 2024-03-18 | 2024-03-20 | $31.27 | $109K | -17.7% | -25.7% | -33.0% |
| FDMT | SELL · 10b5-1 | 2024-02-27 | 2024-02-29 | $30.00 | $57K | -0.8% | +4.3% | -16.7% |
| FDMT | SELL · 10b5-1 | 2024-02-16 | 2024-02-21 | $27.67 | $48K | +8.8% | +27.2% | -4.8% |
| FDMT | SELL · 10b5-1 | 2024-02-08 | 2024-02-12 | $27.50 | $172K | +0.3% | +8.5% | -5.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.